» Articles » PMID: 28972123

A Multilevel Functional Study of a At-Risk Variant for Bipolar Disorder and Schizophrenia

Abstract

The synaptosomal-associated protein SNAP25 is a key player in synaptic vesicle docking and fusion and has been associated with multiple psychiatric conditions, including schizophrenia, bipolar disorder, and attention-deficit/hyperactivity disorder. We recently identified a promoter variant in , , that is associated with early-onset bipolar disorder and a higher gene expression level in human prefrontal cortex. In the current study, we showed that this variant was associated both in males and females with schizophrenia in two independent cohorts. We then combined and approaches in humans to understand the functional impact of the at-risk allele. Thus, we showed that the C allele was sufficient to increase the transcription level. In a postmortem expression analysis of 33 individuals affected with schizophrenia and 30 unaffected control subjects, we showed that the / ratio was increased in schizophrenic patients carrying the at-risk allele. Last, using genetics imaging in a cohort of 71 subjects, we showed that male risk carriers had an increased amygdala-ventromedial prefrontal cortex functional connectivity and a larger amygdala than non-risk carriers. The latter association has been replicated in an independent cohort of 121 independent subjects. Altogether, results from these multilevel functional studies are bringing strong evidence for the functional consequences of this allelic variation of on modulating the development and plasticity of the prefrontal-limbic network, which therefore may increase the vulnerability to both early-onset bipolar disorder and schizophrenia. Functional characterization of disease-associated variants is a key challenge in understanding neuropsychiatric disorders and will open an avenue in the development of personalized treatments. Recent studies have accumulated evidence that the SNARE complex, and more specifically the SNAP25 protein, may be involved in psychiatric disorders. Here, our multilevel functional studies are bringing strong evidence for the functional consequences of an allelic variation of on modulating the development and plasticity of the prefrontal-limbic network. These results demonstrate a common genetically driven functional alteration of a synaptic mechanism both in schizophrenia and early-onset bipolar disorder and confirm the shared genetic vulnerability between these two disorders.

Citing Articles

The Relationship between SNAP25 and Some Common Human Neurological Syndromes.

Shu J, Peng F, Li J, Liu Y, Li X, Yuan C Curr Pharm Des. 2024; 30(30):2378-2386.

PMID: 38963116 DOI: 10.2174/0113816128305683240621060024.


Effects of the SNAP-25 Mnll variant on hippocampal functional connectivity in children with attention deficit/hyperactivity disorder.

Huang W, Fateh A, Zhao Y, Zeng H, Yang B, Fang D Front Hum Neurosci. 2023; 17:1219189.

PMID: 37635807 PMC: 10447972. DOI: 10.3389/fnhum.2023.1219189.


Role of SNAP-25 MnlI variant in impaired working memory and brain functions in attention deficit/hyperactivity disorder.

Fang D, Yang B, Wang P, Mo T, Gan Y, Liang G Brain Behav. 2022; 12(10):e2758.

PMID: 36068994 PMC: 9575616. DOI: 10.1002/brb3.2758.


Dynamic Changes of Brain Cilia Transcriptomes across the Human Lifespan.

Chen S, Alhassen W, Monfared R, Vachirakorntong B, Nauli S, Baldi P Int J Mol Sci. 2021; 22(19).

PMID: 34638726 PMC: 8509004. DOI: 10.3390/ijms221910387.


Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets.

luptak M, Michalickova D, Fisar Z, Kitzlerova E, Hroudova J World J Psychiatry. 2021; 11(7):277-296.

PMID: 34327122 PMC: 8311514. DOI: 10.5498/wjp.v11.i7.277.


References
1.
Thompson P, Rosenberger C, Qualls C . CSF SNAP-25 in schizophrenia and bipolar illness. A pilot study. Neuropsychopharmacology. 2000; 21(6):717-22. DOI: 10.1016/S0893-133X(99)00068-8. View

2.
Barr C, Feng Y, Wigg K, Bloom S, Roberts W, Malone M . Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Mol Psychiatry. 2000; 5(4):405-9. DOI: 10.1038/sj.mp.4000733. View

3.
Torrey E, Webster M, Knable M, Johnston N, Yolken R . The stanley foundation brain collection and neuropathology consortium. Schizophr Res. 2000; 44(2):151-5. DOI: 10.1016/S0920-9964(99)00192-9. View

4.
Fatemi S, Earle J, Stary J, Lee S, Sedgewick J . Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. Neuroreport. 2001; 12(15):3257-62. DOI: 10.1097/00001756-200110290-00023. View

5.
Honer W, Falkai P, Bayer T, Xie J, Hu L, Li H . Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cereb Cortex. 2002; 12(4):349-56. DOI: 10.1093/cercor/12.4.349. View